Discovery of antifungal secondary metabolites from an intestinal fungus Fusarium sp

J Antibiot (Tokyo). 2024 Mar;77(3):193-198. doi: 10.1038/s41429-023-00692-1. Epub 2023 Dec 26.

Abstract

Intestinal fungi, which are important parts of the gut microbiota, have the ability to produce specialized metabolites that significantly contribute to maintaining the balance of the gut microbiota and promoting the health of the host organism. In the present study, two new glycosides, including fusintespyrone A (1) and cerevisterolside A (4), as well as ten known compounds were isolated from the intestinal fungus Fusarium sp. LE06. The structures of the new compounds were elucidated by a combination of spectroscopic methods, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), along with chemical reactions and calculations of NMR and ECD spectra. Compounds 1-3 showed significant growth inhibition against Aspergillus fumigatus, Fusarium oxysporum, and Verticillium dahliae with MIC values in the range of 1.56-6.25 μg ml-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemistry
  • Ascomycota* / metabolism
  • Aspergillus fumigatus / metabolism
  • Fusarium* / metabolism
  • Magnetic Resonance Spectroscopy

Substances

  • Antifungal Agents